University of Granada
Granada, Spain
NCT Number: NCT05925192
Lack of adherence is one of the main problems of chronic musculoskeletal pain treatment. To improve adherence it is essential to take into account the characteristics of the patients and their thoughts and beliefs about pain. Virtual reality can present some advantages in the face of these problems too.
The objective of this study is to evaluate the profile of chronic musculoskeletal pain patients, the barriers associated with lack of adherence to treatment, and the interest of virtual reality in rehabilitation.
This study is active but is not currently recruiting participants.
Notify Me18 year–100 year
All sexes
Observational
Granada, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All those participants who present any physical pathology or of any kind that imply an inability to understand the necessary instructions to carry out the study will be excluded.
N/A - observational study
Time frame: Baseline
To assess pain intensity using the verbal numeric pain scale. Scores range from 0 (no pain) to 10 (worst pain imaginable). Higher scores indicate greater intensity.
Time frame: Baseline
To assess pain intensity and chronic pain interference using the graded chronic pain scale. Scores range from 0 (no pain/no interference) to 10 (worst pain imaginable/unable to carry on any activities). Higher scores indicate greater intensity or interference.
Time frame: Baseline
To assess pain severity using the brief pain inventory. Scores range from 0 (no pain/does not interfere) to 10 (worst pain imaginable/completely interferes). Higher scores indicate greater severity.
Time frame: Baseline
To assess awareness, consciousness, vigilance and observation of pain using the pain vigilance and awareness questionnaire. Scores range from 0 (never) to 5 (always). The total questionnaire scores range between 0 and 80. Higher scores indicate greater awareness, consciousness, vigilance and observation of pain.
Time frame: Baseline
To assess chronic pain acceptance using the chronic pain acceptance questionnaire. Scores range from 0 (never true) to 6 (it is always true). Higher scores indicate greater acceptance.
Time frame: Baseline
To assess neurophysiology of pain using the neurophysiology of pain questionnaire. Scores range from 0 to 13 (sum of all correct items).
Time frame: Baseline
To assess kinesiophobia using the TAMPA scale of kinesiophobia. Scores range from 1 (totally disagree) to 4 (totally agree). The final score can range between 11 and 44 points, with higher scores indicating greater perceived kinesiophobia.
Time frame: Baseline
To assess catastrophizing of pain using the pain catastrophizing scale. Scores range from 0 (nothing at all) to 4 (all the time). The final score range between 0 and 52 points, with higher scores indicating greater levels of catastrophism.
Time frame: Baseline
To assess functionality using the functional independence measure. Scores range from 1 (total assistance) to 7 (complete independence). The final score range between 18 and 126 points, with higher scores indicating greater independence.
Time frame: Baseline
To assess disability using the world health organisation disability assessment. . Scores range from 1 (none) to 5 (extreme). The final score range between 12 and 60 points, with higher scores indicating worst disability.
Time frame: Baseline
To assess level of movement related to space using the life space questionnaire. Scoring is based on "yes" (1 point) or "no" (2 points) answers. The more answers that do "no" exist in the questionnaire, the lower their level of movement in the space will be.
Time frame: Baseline
To assess health-related quality of life using the euroqol-5d. Total score range from 1 (best health status) to 0 (death). The second part of the euroqol-5d is visual analogue scale that goes from 0 (worst state of health imaginable) to 100 (best state of health imaginable).
Time frame: Baseline
To assess sleep quality using the Pittsburgh sleep quality index. The overall score ranges from 0 to 21 points. "0" indicates ease of sleeping and "21" severe difficulty in all areas.
Time frame: Baseline
To assess depression and anxiety using the hospital anxiety and depression scale. The total score ranges from 0 to 21 on each subscale, where a higher score is indicative of more severe symptoms.
Time frame: Baseline
To assess physical activity using the international physical activity questionnaire. This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in Metabolic Equivalent (MET)-min/week and time spent sitting.
Time frame: Baseline
To assess work performance using the work role functioning questionnaire. Total score range from 0% (difficulty all the time) to 100 % (no difficulty at any time).
Time frame: Baseline
To assess social support using the medical outcomes study social support survey
Time frame: Baseline
To assess information about treatment and barriers associated to treatment adherence using Likert-type questions range from 1 (totally disagree) to 5 (totally agree).
Time frame: Baseline
To assess barriers associated to doing exercise therapy using the exercise therapy burden questionnaire. Scores range from 0 (totally disagree) to 10 (totally agree).
Time frame: Baseline
To assess patients' perception to virtual reality rehabilitation using Likert-type questions and yes or no questions
Universidad de Granada
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07449819
Chronic Musculoskeletal Pain
Aveiro, Portugal
View Trial DetailsNCT04994249
Arthralgia, Chronic Musculoskeletal Pain
Palo Alto, California, United States
View Trial DetailsNCT07177547
Anxiety, Anxiety Disorders
Leuven, Belgium
View Trial DetailsNCT07733791
Chronic Musculoskeletal Pain, Delayed Onset Muscle Soreness (DOMS)
View Trial Details